TY - JOUR
T1 - Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression
AU - Nagashima, Katsuyuki
AU - Fukushima, Hidefumi
AU - Shimizu, Kouhei
AU - Yamada, Aya
AU - Hidaka, Masumi
AU - Hasumi, Hisashi
AU - Ikebe, Tetsuro
AU - Fukumoto, Satoshi
AU - Okabe, Koji
AU - Inuzuka, Hiroyuki
N1 - Funding Information:
We thank Dr. Laura S. Schmidt (National Cancer Institute, Bethesda, MD, USA) for UOK-257 and UOK-257-2 cell lines and Dr. Brian J. North (Beth Israel Deaconess Medical Center, Boston, MA, USA) for comments that improved the manuscript. This work was supported by JSPS Kakenhi grants (26253092 to S.F., 16H05548 to A.Y., 26462829 to H.F., and 16H055290 to H.I.) and in part by the American Cancer Society and Charles H. Hood Foundation.
PY - 2017
Y1 - 2017
N2 - Folliculin-interacting protein 1 and 2 (FNIP1 and FNIP2) play critical roles in preventing renal malignancy through their association with the tumor suppressor FLCN. Mutations in FLCN are associated with Birt-Hogg-Dubé (BHD) syndrome, a rare disorder with increased risk of renal cancer. Recent studies indicated that FNIP1/FNIP2 double knockout mice display enlarged polycystic kidneys and renal carcinoma, which phenocopies FLCN knockout mice, suggesting that these two proteins function together to suppress renal cancer. However, the molecular mechanism functionally linking FNIP1/FNIP2 and FLCN remains largely elusive. Here, we demonstrated that FNIP2 protein is unstable and subjected to proteasome-dependent degradation via β-TRCP and Casein Kinase 1 (CK1)-directed ubiquitination in a nutrition-dependent manner. Degradation of FNIP2 leads to lysosomal dissociation of FLCN and subsequent lysosomal association of mTOR, which in turn promotes the proliferation of renal cancer cells. These results indicate that SCFβ-TRCP negatively regulates the FLCN complex by promoting FNIP degradation and provide molecular insight into the pathogenesis of BHD-associated renal cancer.
AB - Folliculin-interacting protein 1 and 2 (FNIP1 and FNIP2) play critical roles in preventing renal malignancy through their association with the tumor suppressor FLCN. Mutations in FLCN are associated with Birt-Hogg-Dubé (BHD) syndrome, a rare disorder with increased risk of renal cancer. Recent studies indicated that FNIP1/FNIP2 double knockout mice display enlarged polycystic kidneys and renal carcinoma, which phenocopies FLCN knockout mice, suggesting that these two proteins function together to suppress renal cancer. However, the molecular mechanism functionally linking FNIP1/FNIP2 and FLCN remains largely elusive. Here, we demonstrated that FNIP2 protein is unstable and subjected to proteasome-dependent degradation via β-TRCP and Casein Kinase 1 (CK1)-directed ubiquitination in a nutrition-dependent manner. Degradation of FNIP2 leads to lysosomal dissociation of FLCN and subsequent lysosomal association of mTOR, which in turn promotes the proliferation of renal cancer cells. These results indicate that SCFβ-TRCP negatively regulates the FLCN complex by promoting FNIP degradation and provide molecular insight into the pathogenesis of BHD-associated renal cancer.
UR - http://www.scopus.com/inward/record.url?scp=85012000610&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85012000610&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.14221
DO - 10.18632/oncotarget.14221
M3 - Article
C2 - 28039480
AN - SCOPUS:85012000610
SN - 1949-2553
VL - 8
SP - 9947
EP - 9960
JO - Oncotarget
JF - Oncotarget
IS - 6
ER -